Development of novel drug for bone-related diseases using Pirin inhibitors
Project/Area Number |
24310167
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Chemical biology
|
Research Institution | Keio University |
Principal Investigator |
SIMIZU Siro 慶應義塾大学, 理工学部, 准教授 (30312268)
|
Co-Investigator(Renkei-kenkyūsha) |
UMEZAWA Kazuo 愛知医科大学, 医学部, 教授 (70114402)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000)
Fiscal Year 2014: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2013: ¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2012: ¥8,320,000 (Direct Cost: ¥6,400,000、Indirect Cost: ¥1,920,000)
|
Keywords | 骨関連疾患 / Pirin / 破骨細胞 / 破骨細胞分化 / ケミカルバイオロジー / RANKL / 骨疾患 / 低分子化合物 / 骨粗鬆症 / 骨転移 / 構造活性相関 |
Outline of Final Research Achievements |
The number of bone-related disease patients is increasing in Japan. At present, bisphosphonates are widely used for these diseases, but their severe side effects are impossible to ignore. We focused on TPh A, a Pirin inhibitor, as a novel drug for such diseases. We assayed many derivatives of TPh A and found that 2 compounds inhibited RANKL-induced osteoclastgenesis on Pirin-independent manner without cytotoxicity. These compounds did not suppress phosphorylation of MAPKs, although its inhibited expression of c-Fos and DC-STAMP. Therefore, it is suggested that the compounds we found might be candidates for drugs of bone-related diseases.
|
Report
(4 results)
Research Products
(57 results)
-
-
-
-
-
-
-
[Journal Article] N-glycosylation is required for secretion and enzymatic activity of human hyaluronidase1.2014
Author(s)
Goto, Y., Niwa, Y., Suzuki, T., Uematsu, S., Dohmae, N. & Simizu, S.
-
Journal Title
FEBS Open Bio
Volume: 4
Issue: 1
Pages: 554-559
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
[Journal Article] C-mannosylation of human hyaluronidase 1: Possible roles for secretion and enzymatic activity.2014
Author(s)
Goto, Y., Niwa, Y., Suzuki, T., Dohmae, N., Umezawa, K. & Simizu, S.
-
Journal Title
Int. J. Oncol.
Volume: 45
Issue: 1
Pages: 344-350
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
[Journal Article] Determination of topological structure of ARL6ip1 in cells: identification of the essential binding region of ARL6ip1 for conophylline2013
Author(s)
Kuroda, M., Funasaki, S., Saitoh, T., Sasazawa, Y., Nishiyama, S., Umezawa, K. & Simizu, S.
-
Journal Title
FEBS Letters
Volume: 587
Issue: 22
Pages: 3656-3660
DOI
Related Report
Peer Reviewed
-
[Journal Article] Migracins A and B, new inhibitors of cancer cell migration, produced by Streptomyces sp2013
Author(s)
Arai, Y., Iinuma, H., Ikeda, Y., Igarashi, M., Hatano, M., Kinoshita, N., Ukaji, T., Simizu, S. & Umezawa, K
-
Journal Title
The Journal of Antibiotics
Volume: (掲載決定)
Issue: 4
Pages: 225-230
DOI
NAID
Related Report
Peer Reviewed
-
[Journal Article] Inhibition of NO-induced β-cell death by novel NF-κB inhibitor (-)-DHMEQ via activation of Nrf2-ARE pathway2013
Author(s)
Ogasawara, A., Simizu, S., Ito, A., Kawai, T., Saisho, Y., Takei, I. & Umezawa, K
-
Journal Title
Biochemical and Biophysical Research Communications
Volume: (掲載決定)
Issue: 2
Pages: 181-187
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Inhibition of lysenin-induced hemolysis by all-E-lutein derived from the plant Dalbergia latifolia2012
Author(s)
Niwa, Y., Matsui, C., Sukumwang, N., Iinuma, H., Ikeda, Y., Koyano, T., Kovitayakorn, T., Simizu, S. & Umezawa, K
-
Journal Title
Planta Medica
Volume: 78
Issue: 10
Pages: 957-961
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] N型糖鎖修飾がHYAL1機能に与える影響2014
Author(s)
後藤 祐貴、丹羽 祐貴、堂前 直、清水 史郎
Organizer
日本がん分子標的治療学会 第18回学術集会
Place of Presentation
仙台市情報・産業プラザ(宮城県・仙台市)
Year and Date
2014-06-25 – 2014-06-27
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-